RATIONALE

The incidence and diagnosis of viral, bacterial and fungal infections in the critically ill patient has dramatically increased in the last few years. Fungal infections in the neutropenic and immunocompromised patients, as well as in those receiving immunosuppressive drugs, account for a large number of cases, but bacterial and viral infections are also increasingly frequent. In addition, resistance to antimicrobial drugs may jeopardize the success of therapeutic interventions.

Treatment of infections in the critically ill is still fraught with a number of open questions. This symposium aims at highlighting these issues and providing a discussion forum for clinicians and microbiologists actively involved in the treatment of infections in ICU and immunocompromised patients.

OBJECTIVES

The symposium aims at addressing common issues and controversies relating to the treatment of infections in critically ill patients, and to provide the participants with information that can be used in the daily clinical practice.

SCIENTIFIC COMMITTEE

• Francesco Scaglione (President)
• Enos Bernasconi
• Gianni Di Perri
• Paolo Grossi
• Oscar Marchetti
• Orlando Petrini